Analysis of paired bone marrow (BM) and extramedullary samples revealed that extramedullary multiple myeloma (MM) cells lacked CD56 expression, while BM myeloma cells exhibited varying levels of CD56 expression, further supporting the role of CD56 in extramedullary dissemination [61]. The gene discussed is NCAM1; the disease is plasma cell myeloma.